Literature DB >> 18174231

New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes.

L Maksimovic1, J Stirnemann, F Caux, N Ravet, S Rouaghe, L Cuisset, E Letellier, G Grateau, A-S Morin, O Fain.   

Abstract

OBJECTIVES: Muckle-Wells syndrome (MWS) and familial cold autoinflammatory syndrome (FCAS) are rare periodic fevers associated with CIAS1 mutations. A third entity, the chronic infantile neurological, cutaneous, articular (CINCA) syndrome was also recently associated with mutation in the same gene. A phenotypic and genotypic continuum seems to exist from the most benign (FCAS) to the most severe forms (CINCA). Although a CIAS1 mutation can be associated with two different phenotypes.
METHODS: We report a family of three patients exhibiting the MWS and FCAS phenotypes. These phenotypes were associated with a novel missense mutation in CIAS1.
RESULTS: Anakinra controlled inflammatory flares in the three patients.
CONCLUSIONS: FCAS, MWS and CINCA could be different phenotype expressions of the same disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18174231     DOI: 10.1093/rheumatology/kem318

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  13 in total

Review 1.  Targeting Toll-like receptors: emerging therapeutics?

Authors:  Elizabeth J Hennessy; Andrew E Parker; Luke A J O'Neill
Journal:  Nat Rev Drug Discov       Date:  2010-04       Impact factor: 84.694

Review 2.  Monogenic IL-1 mediated autoinflammatory and immunodeficiency syndromes: finding the right balance in response to danger signals.

Authors:  Cailin Henderson; Raphaela Goldbach-Mansky
Journal:  Clin Immunol       Date:  2010-03-30       Impact factor: 3.969

3.  Critical appraisal of canakinumab in the treatment of adults and children with cryopyrin-associated periodic syndrome (CAPS).

Authors:  Ori Toker; Philip J Hashkes
Journal:  Biologics       Date:  2010-05-25

Review 4.  Monogenic Autoinflammatory Diseases with Mendelian Inheritance: Genes, Mutations, and Genotype/Phenotype Correlations.

Authors:  Davide Martorana; Francesco Bonatti; Paola Mozzoni; Augusto Vaglio; Antonio Percesepe
Journal:  Front Immunol       Date:  2017-04-03       Impact factor: 7.561

Review 5.  Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory Diseases.

Authors:  Alessandra Bettiol; Giuseppe Lopalco; Giacomo Emmi; Luca Cantarini; Maria Letizia Urban; Antonio Vitale; Nunzio Denora; Antonio Lopalco; Annalisa Cutrignelli; Angela Lopedota; Vincenzo Venerito; Marco Fornaro; Alfredo Vannacci; Donato Rigante; Rolando Cimaz; Florenzo Iannone
Journal:  Int J Mol Sci       Date:  2019-04-17       Impact factor: 5.923

Review 6.  IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives.

Authors:  Hana Malcova; Zuzana Strizova; Tomas Milota; Ilja Striz; Anna Sediva; Dita Cebecauerova; Rudolf Horvath
Journal:  Front Immunol       Date:  2021-02-01       Impact factor: 7.561

Review 7.  NOD-like receptors and inflammation.

Authors:  Rebeccah J Mathews; Michael B Sprakes; Michael F McDermott
Journal:  Arthritis Res Ther       Date:  2008-11-25       Impact factor: 5.156

8.  Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap).

Authors:  Leigh D Church; Sinisa Savic; Michael F McDermott
Journal:  Biologics       Date:  2008-12

Review 9.  From the Mediterranean to the sea of Japan: the transcontinental odyssey of autoinflammatory diseases.

Authors:  Donato Rigante; Bruno Frediani; Mauro Galeazzi; Luca Cantarini
Journal:  Biomed Res Int       Date:  2013-07-23       Impact factor: 3.411

10.  Muckle-Wells Syndrome Across Four Generations in One Czech Family: Natural Course of the Disease.

Authors:  Šárka Fingerhutová; Jana Fráňová; Eva Hlaváčková; Eva Jančová; Leona Procházková; Kamila Beránková; Markéta Tesařová; Eva Honsová; Pavla Doležalová
Journal:  Front Immunol       Date:  2019-04-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.